Thakku Sivakumar, D.; Jain, K.; Alfehaid, N.; Wang, Y.; Teng, X.; Fischer, W.; Engel, T.
The Purinergic P2X7 Receptor as a Target for Adjunctive Treatment for Drug-Refractory Epilepsy. Int. J. Mol. Sci. 2024, 25, 6894.
https://doi.org/10.3390/ijms25136894
AMA Style
Thakku Sivakumar D, Jain K, Alfehaid N, Wang Y, Teng X, Fischer W, Engel T.
The Purinergic P2X7 Receptor as a Target for Adjunctive Treatment for Drug-Refractory Epilepsy. International Journal of Molecular Sciences. 2024; 25(13):6894.
https://doi.org/10.3390/ijms25136894
Chicago/Turabian Style
Thakku Sivakumar, Divyeshz, Krishi Jain, Noura Alfehaid, Yitao Wang, Xinchen Teng, Wolfgang Fischer, and Tobias Engel.
2024. "The Purinergic P2X7 Receptor as a Target for Adjunctive Treatment for Drug-Refractory Epilepsy" International Journal of Molecular Sciences 25, no. 13: 6894.
https://doi.org/10.3390/ijms25136894
APA Style
Thakku Sivakumar, D., Jain, K., Alfehaid, N., Wang, Y., Teng, X., Fischer, W., & Engel, T.
(2024). The Purinergic P2X7 Receptor as a Target for Adjunctive Treatment for Drug-Refractory Epilepsy. International Journal of Molecular Sciences, 25(13), 6894.
https://doi.org/10.3390/ijms25136894
